T1	Life-Stage-And-Gender 25 31	Female
A1	Life-Stage-And-Gender-Value T1 female
T2	And 32 36	with
T3	Condition-Name 60 73	endometriosis
T4	Procedure-Name 90 101	laparoscopy
T5	Eq-Operator 112 118	within
A2	Eq-Operator-Value T5 LTEQ
T6	Eq-Value 119 120	3
T7	Study 132 137	study
T8	Age 151 154	Age
T9	Eq-Value 155 157	15
T10	Eq-Temporal-Unit 158 163	years
A3	Eq-Temporal-Unit-Value T10 year
T11	Eq-Operator 164 166	to
A4	Eq-Operator-Value T11 BETWEEN
T12	Eq-Temporal-Period 180 187	Current
A5	Eq-Temporal-Period-Value T12 present
T13	Eq-Operator 192 193	≥
A6	Eq-Operator-Value T13 GTEQ
T14	Eq-Comparison 192 202	≥ 2 months
T15	Eq-Value 194 195	2
T16	Eq-Temporal-Unit 196 202	months
A7	Eq-Temporal-Unit-Value T16 month
T17	Procedure-Name 215 231	hormonal therapy
T18	Drug-Name 240 268	combined oral contraceptives
T19	Drug-Name 271 292	norethindrone acetate
T20	Eq-Temporal-Period 337 344	Current
A8	Eq-Temporal-Period-Value T20 present
T21	Condition-Name 345 356	pelvic pain
T22	Eq-Unit 359 364	score
T23	Eq-Comparison 359 368	score ≥ 3
T24	Eq-Operator 365 366	≥
A9	Eq-Operator-Value T24 GTEQ
T25	Eq-Comparison 365 368	≥ 3
T26	Eq-Value 367 368	3
T27	Observation-Name 372 391	Visual Analog Scale
T28	Negation 413 420	absence
T29	Condition-Name 424 428	pain
T30	Eq-Value 433 435	10
T31	Condition-Name 446 461	unbearable pain
T32	Condition-Name 457 461	pain
T33	Eq-Operator 476 477	≥
A10	Eq-Operator-Value T33 GTEQ
T34	Eq-Comparison 476 485	≥ 14 days
T35	Eq-Comparison 476 493	≥ 14 days / month
T36	Eq-Value 478 480	14
T37	Eq-Temporal-Unit 481 485	days
A11	Eq-Temporal-Unit-Value T37 day
T38	Eq-Temporal-Unit 488 493	month
A12	Eq-Temporal-Unit-Value T38 month
T39	Drug 662 679	Contraindications
T40	Drug-Name 683 694	cabergoline
T41	Condition-Name 704 726	cardiac valve disorder
T42	Modifier 729 738	pulmonary
T43	Modifier 741 752	pericardial
T44	Modifier 755 770	retroperitoneal
T45	Condition-Name 791 807	hypersensitivity
T46	Drug-Name 811 828	ergot derivatives
T47	Modifier 875 881	mental
T48	Or 882 884	or
T49	Modifier 885 892	chronic
T50	Modifier 893 901	systemic
T51	Condition 902 909	illness
T52	Assertion 915 920	might
T53	Condition-Name 998 1011	breastfeeding
T54	Condition-Name 1069 1093	 Impaired liver function
T55	Condition-Name 1070 1093	Impaired liver function
T56	Observation-Name 1096 1099	ALT
A13	Observation-Name-Value T56 lab
T57	Eq-Operator 1100 1101	>
A14	Eq-Operator-Value T57 GT
T58	Eq-Value 1102 1103	2
T59	Other 1232 1237	other
T60	Drug 1238 1243	drugs
T61	Stability 1249 1255	affect
A15	Stability-Value T61 change
T62	Drug-Name 1256 1264	dopamine
T63	Drug-Name 1274 1288	phenothiazines
T64	Unknown 240 268	combined oral contraceptives
T65	Unknown 215 231	hormonal therapy
R1	Example-Of Arg1:T64 Arg2:T65
T66	Unknown 271 292	norethindrone acetate
T67	Unknown 215 231	hormonal therapy
R2	Example-Of Arg1:T66 Arg2:T67
T68	Unknown 704 726	cardiac valve disorder
T69	Unknown 661 661	
R3	Example-Of Arg1:T68 Arg2:T69
T70	Unknown 704 726	cardiac valve disorder
T71	Unknown 662 679	Contraindications
R4	Example-Of Arg1:T70 Arg2:T71
T72	Unknown 791 807	hypersensitivity
T73	Unknown 661 661	
R5	Example-Of Arg1:T72 Arg2:T73
T74	Unknown 791 807	hypersensitivity
T75	Unknown 662 679	Contraindications
R6	Example-Of Arg1:T74 Arg2:T75
T76	Unknown 885 892	chronic
T77	Unknown 902 909	illness
R7	Abbrev-Of Arg1:T76 Arg2:T77
T78	Unknown 893 901	systemic
T79	Unknown 902 909	illness
R8	Abbrev-Of Arg1:T78 Arg2:T79
T80	Unknown 1249 1255	affect
T81	Unknown 1238 1243	drugs
R9	Caused-By Arg1:T80 Arg2:T81
T82	Unknown 1249 1255	affect
T83	Unknown 1256 1264	dopamine
R10	Caused-By Arg1:T82 Arg2:T83
T84	Unknown 1274 1288	phenothiazines
T85	Unknown 1238 1243	drugs
R11	Example-Of Arg1:T84 Arg2:T85